Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Wells Messersmith

Concepts (659)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Colorectal Neoplasms
59
2025
874
7.890
Why?
Pancreatic Neoplasms
43
2026
944
4.700
Why?
Antineoplastic Agents
62
2024
2219
4.450
Why?
Antineoplastic Combined Chemotherapy Protocols
53
2026
1998
4.210
Why?
Adenocarcinoma
22
2026
927
2.960
Why?
Neoplasms
43
2022
2954
2.480
Why?
Protein Kinase Inhibitors
21
2020
983
2.200
Why?
Xenograft Model Antitumor Assays
35
2025
930
2.000
Why?
Amyloid Precursor Protein Secretases
7
2021
80
2.000
Why?
Deoxycytidine
19
2025
219
1.990
Why?
Camptothecin
19
2025
139
1.900
Why?
Antibodies, Monoclonal, Humanized
29
2025
992
1.800
Why?
Liver Neoplasms
11
2025
776
1.770
Why?
Immunoconjugates
12
2021
138
1.700
Why?
Colonic Neoplasms
11
2026
259
1.580
Why?
Carcinoma, Pancreatic Ductal
11
2025
297
1.520
Why?
Antibodies, Monoclonal
21
2024
1512
1.420
Why?
Quinazolines
11
2015
267
1.370
Why?
Drug Resistance, Neoplasm
16
2025
893
1.330
Why?
Tetrahydronaphthalenes
3
2017
34
1.320
Why?
Valine
3
2017
84
1.290
Why?
ErbB Receptors
14
2016
636
1.270
Why?
src-Family Kinases
4
2017
93
1.250
Why?
Molecular Targeted Therapy
11
2024
447
1.170
Why?
ras Proteins
10
2017
148
1.160
Why?
Maximum Tolerated Dose
23
2026
217
1.160
Why?
Fluorouracil
15
2025
231
1.110
Why?
Rectal Neoplasms
8
2024
160
1.060
Why?
Enzyme Inhibitors
9
2020
823
1.050
Why?
Benzodioxoles
5
2012
164
1.040
Why?
Humans
206
2026
146342
1.030
Why?
Cetuximab
11
2025
110
1.030
Why?
Phosphatidylinositol 3-Kinases
11
2018
384
0.990
Why?
Mutation
16
2026
4093
0.990
Why?
Bevacizumab
8
2024
169
0.960
Why?
Biomarkers, Tumor
14
2026
1339
0.900
Why?
Aged
82
2026
26432
0.900
Why?
CD47 Antigen
1
2025
41
0.900
Why?
Pyridines
9
2022
610
0.890
Why?
Gastrointestinal Neoplasms
3
2026
74
0.870
Why?
Wnt Signaling Pathway
8
2024
211
0.860
Why?
Cell Line, Tumor
33
2025
3545
0.860
Why?
Proto-Oncogene Proteins
13
2018
616
0.860
Why?
Benzimidazoles
7
2024
191
0.840
Why?
Middle Aged
88
2026
36619
0.830
Why?
Neoadjuvant Therapy
13
2026
475
0.820
Why?
Anilides
3
2022
83
0.810
Why?
Receptor, Notch1
3
2015
62
0.810
Why?
Aldehyde Dehydrogenase
6
2017
98
0.810
Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2023
139
0.780
Why?
Drugs, Investigational
2
2015
31
0.770
Why?
Mice, Nude
24
2024
668
0.760
Why?
Signal Transduction
22
2019
5246
0.760
Why?
Aniline Compounds
4
2011
120
0.750
Why?
Immunotherapy
5
2022
671
0.730
Why?
Medical Oncology
9
2025
345
0.720
Why?
Female
113
2026
79499
0.710
Why?
Quinolines
4
2022
191
0.700
Why?
Treatment Outcome
43
2026
11821
0.670
Why?
Paclitaxel
9
2025
260
0.660
Why?
Nitriles
3
2011
212
0.660
Why?
Dose-Response Relationship, Drug
23
2017
2022
0.650
Why?
Neoplasm Metastasis
16
2025
693
0.640
Why?
Vascular Endothelial Growth Factor A
3
2022
545
0.640
Why?
Mice
44
2025
18297
0.620
Why?
Drug Design
6
2022
180
0.620
Why?
Carcinoma
3
2011
225
0.610
Why?
Antineoplastic Agents, Immunological
4
2020
200
0.600
Why?
Sulfones
4
2015
127
0.600
Why?
Gene Dosage
3
2015
146
0.600
Why?
Adult
70
2026
41087
0.600
Why?
Dasatinib
2
2017
58
0.590
Why?
Administration, Oral
14
2017
872
0.590
Why?
Pancreatectomy
4
2026
289
0.590
Why?
Animals
58
2025
38107
0.590
Why?
Aged, 80 and over
33
2026
8391
0.590
Why?
Glycine
4
2015
184
0.590
Why?
Neoplasm Staging
17
2024
1488
0.580
Why?
Male
87
2026
73396
0.570
Why?
Embolization, Therapeutic
1
2021
246
0.570
Why?
Practice Guidelines as Topic
6
2020
1591
0.560
Why?
Pyrimidinones
4
2015
124
0.560
Why?
MAP Kinase Kinase 1
3
2015
70
0.560
Why?
Receptors, Notch
3
2015
92
0.560
Why?
Tumor Microenvironment
7
2023
747
0.550
Why?
Oncogene Proteins v-abl
1
2017
5
0.530
Why?
Pyrimidines
7
2022
532
0.530
Why?
Liver Transplantation
1
2025
751
0.530
Why?
Pyridones
4
2015
210
0.520
Why?
Albumins
6
2025
120
0.500
Why?
DNA Helicases
3
2024
138
0.490
Why?
Phenylurea Compounds
7
2022
122
0.490
Why?
Benzazepines
2
2014
36
0.490
Why?
MAP Kinase Kinase Kinases
4
2015
70
0.480
Why?
Antigens, Neoplasm
8
2018
271
0.470
Why?
Disease Models, Animal
10
2024
4580
0.470
Why?
Recombinant Fusion Proteins
4
2025
663
0.460
Why?
Autophagy
1
2018
290
0.460
Why?
Carcinoma, Squamous Cell
5
2023
628
0.460
Why?
Angiogenesis Inhibitors
8
2018
239
0.460
Why?
MAP Kinase Kinase 2
2
2012
28
0.460
Why?
Immunoglobulin Fc Fragments
3
2021
41
0.450
Why?
Apoptosis
14
2022
2439
0.450
Why?
Microsatellite Instability
5
2025
57
0.440
Why?
Drug Administration Schedule
14
2017
790
0.440
Why?
Patient Rights
1
2015
11
0.440
Why?
Disease-Free Survival
11
2023
778
0.440
Why?
Cell Proliferation
18
2024
2502
0.440
Why?
Therapies, Investigational
1
2015
18
0.430
Why?
Drug and Narcotic Control
1
2015
24
0.430
Why?
Combined Modality Therapy
8
2024
1271
0.430
Why?
3' Untranslated Regions
2
2012
152
0.430
Why?
Leucovorin
9
2025
98
0.420
Why?
Chemotherapy, Adjuvant
8
2026
429
0.420
Why?
DNA Copy Number Variations
1
2015
192
0.420
Why?
DNA-Binding Proteins
5
2024
1468
0.410
Why?
Receptors, Enterotoxin
3
2026
4
0.410
Why?
Azepines
3
2020
104
0.390
Why?
Mitogen-Activated Protein Kinases
2
2014
288
0.380
Why?
Prognosis
10
2023
4351
0.370
Why?
Epithelial-Mesenchymal Transition
5
2021
219
0.370
Why?
Methylurea Compounds
3
2006
7
0.360
Why?
Neutropenia
7
2022
153
0.350
Why?
Proto-Oncogene Proteins p21(ras)
10
2019
250
0.350
Why?
Class I Phosphatidylinositol 3-Kinases
5
2019
111
0.340
Why?
Triple Negative Breast Neoplasms
3
2019
220
0.340
Why?
Cell Adhesion Molecules
5
2018
180
0.330
Why?
Terminal Care
1
2015
284
0.330
Why?
Anus Neoplasms
2
2023
33
0.320
Why?
Gamma Rays
2
2021
56
0.320
Why?
Survival Rate
9
2025
2092
0.320
Why?
Area Under Curve
9
2018
335
0.310
Why?
Genes, ras
2
2018
70
0.310
Why?
Thymidylate Synthase
1
2010
13
0.310
Why?
Drug Synergism
2
2024
354
0.300
Why?
TOR Serine-Threonine Kinases
5
2018
455
0.300
Why?
Faculty, Medical
2
2025
309
0.300
Why?
Pancreaticoduodenectomy
1
2010
149
0.300
Why?
Phthalazines
2
2023
64
0.300
Why?
Immunoblotting
6
2015
294
0.290
Why?
Proto-Oncogene Proteins B-raf
7
2026
231
0.290
Why?
Enhancer Elements, Genetic
1
2010
190
0.280
Why?
Immunohistochemistry
9
2019
1712
0.270
Why?
Cell Cycle Proteins
5
2018
630
0.270
Why?
Metabolic Clearance Rate
6
2012
115
0.260
Why?
Sirolimus
4
2012
282
0.260
Why?
Topoisomerase II Inhibitors
2
2019
24
0.260
Why?
Organoplatinum Compounds
6
2014
65
0.250
Why?
Programmed Cell Death 1 Receptor
2
2020
268
0.250
Why?
SOXB1 Transcription Factors
2
2018
66
0.250
Why?
Membrane Proteins
6
2021
1130
0.250
Why?
Clinical Trials as Topic
8
2024
1064
0.250
Why?
Receptors, G-Protein-Coupled
2
2020
233
0.250
Why?
Pyrazoles
4
2022
517
0.240
Why?
Genetic Testing
1
2009
492
0.240
Why?
Neovascularization, Pathologic
3
2018
287
0.240
Why?
Neoplasm Recurrence, Local
5
2023
1160
0.240
Why?
Diarrhea
2
2026
190
0.240
Why?
Health Services Accessibility
1
2015
1107
0.240
Why?
Capecitabine
4
2015
56
0.240
Why?
CD3 Complex
1
2026
113
0.240
Why?
Mesenteric Artery, Superior
1
2026
28
0.230
Why?
Vascular Endothelial Growth Factor Receptor-2
3
2015
87
0.230
Why?
Gene Expression Regulation, Neoplastic
8
2020
1432
0.230
Why?
Chemoembolization, Therapeutic
3
2013
88
0.230
Why?
Protein-Lysine 6-Oxidase
1
2025
14
0.230
Why?
Head and Neck Neoplasms
3
2016
563
0.230
Why?
Antibodies, Bispecific
1
2026
70
0.230
Why?
Lung Neoplasms
4
2023
2675
0.220
Why?
Heterografts
3
2021
143
0.220
Why?
Proto-Oncogene Proteins c-akt
4
2018
441
0.220
Why?
Mice, Inbred BALB C
2
2025
1244
0.220
Why?
Survival Analysis
7
2017
1378
0.220
Why?
Neoplasm Proteins
4
2020
444
0.220
Why?
Cyclosporine
2
2018
256
0.210
Why?
Neoplastic Stem Cells
3
2018
403
0.210
Why?
Carcinoma, Non-Small-Cell Lung
4
2017
1195
0.210
Why?
Drug Discovery
3
2016
154
0.210
Why?
MAP Kinase Signaling System
1
2006
307
0.210
Why?
Collagen Type I
1
2025
144
0.210
Why?
Follow-Up Studies
7
2021
5439
0.210
Why?
Sulfonamides
4
2022
594
0.210
Why?
Carcinoma, Hepatocellular
3
2016
370
0.210
Why?
Retrospective Studies
14
2026
17438
0.210
Why?
cdc25 Phosphatases
1
2024
13
0.200
Why?
Oligonucleotide Array Sequence Analysis
5
2015
752
0.200
Why?
Lymphoma, Non-Hodgkin
1
2025
124
0.200
Why?
Erlotinib Hydrochloride
5
2015
71
0.200
Why?
Societies, Medical
2
2018
907
0.200
Why?
Positron-Emission Tomography
3
2018
343
0.200
Why?
Oncologists
1
2024
47
0.200
Why?
STAT3 Transcription Factor
3
2022
214
0.200
Why?
DNA Mismatch Repair
3
2021
54
0.190
Why?
Subacute Care
1
2024
85
0.190
Why?
Metastasectomy
1
2023
19
0.190
Why?
TCF Transcription Factors
2
2020
19
0.190
Why?
Colon
1
2005
304
0.190
Why?
DNA
1
2009
1421
0.190
Why?
Perioperative Care
1
2025
235
0.190
Why?
DNA Mutational Analysis
5
2012
410
0.190
Why?
Collagen
1
2025
460
0.190
Why?
Pyrazines
2
2018
94
0.180
Why?
Cancer Care Facilities
2
2016
48
0.180
Why?
HCT116 Cells
4
2018
78
0.180
Why?
Ephrin-B2
2
2021
45
0.180
Why?
Biopsy
5
2023
1075
0.180
Why?
Time Factors
9
2017
7109
0.180
Why?
Skilled Nursing Facilities
1
2024
152
0.180
Why?
DNA Topoisomerases, Type II
3
2019
42
0.180
Why?
NLR Family, Pyrin Domain-Containing 3 Protein
1
2023
167
0.180
Why?
Cell Cycle
4
2018
595
0.180
Why?
Image Processing, Computer-Assisted
2
2006
778
0.180
Why?
Forecasting
1
2023
388
0.170
Why?
Colic
1
2001
10
0.170
Why?
Chemoradiotherapy, Adjuvant
2
2023
44
0.170
Why?
Kaplan-Meier Estimate
6
2025
970
0.170
Why?
Yttrium Radioisotopes
1
2021
64
0.170
Why?
Tumor Burden
5
2018
326
0.170
Why?
Gene Regulatory Networks
1
2024
319
0.170
Why?
Disease Management
3
2024
651
0.170
Why?
Infusions, Intravenous
4
2017
432
0.170
Why?
Tumor Cells, Cultured
5
2021
882
0.170
Why?
Trastuzumab
1
2021
119
0.170
Why?
Radiosurgery
2
2025
398
0.160
Why?
ADAM10 Protein
1
2021
29
0.160
Why?
Tissue Distribution
2
2012
334
0.160
Why?
Neoplasms, Second Primary
1
2022
103
0.160
Why?
Gene Expression Profiling
5
2024
1792
0.160
Why?
Histone Deacetylase Inhibitors
3
2019
219
0.160
Why?
Gene Knockdown Techniques
3
2020
335
0.160
Why?
Abdomen
1
2001
142
0.160
Why?
Momordica charantia
1
2020
14
0.160
Why?
Cell Plasticity
1
2021
37
0.160
Why?
Aurora Kinase A
2
2020
57
0.160
Why?
Benzoxazoles
1
2020
20
0.160
Why?
Neoplasm Transplantation
6
2018
238
0.160
Why?
Topoisomerase I Inhibitors
3
2017
20
0.160
Why?
Oligonucleotides, Antisense
1
2020
122
0.150
Why?
In Situ Hybridization, Fluorescence
2
2012
334
0.150
Why?
Diagnostic Errors
1
2001
178
0.150
Why?
Lymphoma
1
2022
251
0.150
Why?
Peptide Fragments
1
2024
693
0.150
Why?
Half-Life
3
2017
157
0.150
Why?
Imidazoles
2
2018
245
0.150
Why?
Immune System
1
2021
181
0.150
Why?
Myeloid-Derived Suppressor Cells
1
2020
78
0.150
Why?
Radiation Injuries
1
2021
149
0.150
Why?
Intestinal Neoplasms
1
2019
31
0.150
Why?
Postoperative Complications
2
2026
3034
0.150
Why?
Disease Progression
8
2025
2867
0.150
Why?
Cell Transformation, Neoplastic
2
2018
314
0.150
Why?
Neoplasm Invasiveness
4
2020
504
0.150
Why?
Pancreas
2
2022
343
0.140
Why?
Antineoplastic Agents, Phytogenic
3
2017
178
0.140
Why?
Benchmarking
1
2020
193
0.140
Why?
Antimetabolites, Antineoplastic
2
2020
108
0.140
Why?
Physician-Patient Relations
1
2024
597
0.140
Why?
Phosphatidylinositol 3-Kinase
2
2016
24
0.140
Why?
Receptor, EphB4
1
2019
33
0.140
Why?
Benzamides
3
2014
226
0.140
Why?
Melanoma
2
2018
765
0.140
Why?
Oligopeptides
2
2018
264
0.140
Why?
Adrenal Cortex Neoplasms
1
2020
70
0.140
Why?
Adrenocortical Carcinoma
1
2020
72
0.140
Why?
CDC2 Protein Kinase
1
2018
26
0.140
Why?
United States
10
2024
16136
0.140
Why?
Plant Extracts
1
2020
192
0.140
Why?
Biomedical Research
1
2025
729
0.140
Why?
Patient Compliance
2
2021
589
0.140
Why?
Molecular Diagnostic Techniques
1
2019
104
0.140
Why?
Intestine, Small
1
2019
160
0.140
Why?
Tomography, X-Ray Computed
4
2010
2786
0.140
Why?
Fibrosis
1
2021
568
0.140
Why?
Aminobenzoates
1
2018
7
0.130
Why?
Neoplasm Grading
1
2019
313
0.130
Why?
Piperazines
2
2022
368
0.130
Why?
Tumor Suppressor Protein p53
3
2019
530
0.130
Why?
TWEAK Receptor
1
2017
6
0.130
Why?
Chemoradiotherapy
4
2023
238
0.130
Why?
Antibiotics, Antineoplastic
2
2009
141
0.130
Why?
Cytochrome P-450 CYP3A
3
2008
93
0.130
Why?
Communication
1
2024
980
0.130
Why?
Patient Discharge
1
2024
997
0.130
Why?
Kidney Diseases
1
2001
428
0.130
Why?
Endoscopic Ultrasound-Guided Fine Needle Aspiration
1
2017
62
0.130
Why?
Breast Neoplasms, Male
1
2017
29
0.130
Why?
Intercellular Signaling Peptides and Proteins
2
2015
372
0.120
Why?
Cytochrome P-450 Enzyme System
3
2008
163
0.120
Why?
beta Catenin
2
2016
250
0.120
Why?
Taxoids
2
2008
115
0.120
Why?
Diagnostic Tests, Routine
1
2017
109
0.120
Why?
Hospitals, High-Volume
1
2016
51
0.120
Why?
Physicians
1
2025
955
0.120
Why?
Guanylate Cyclase
1
2016
36
0.120
Why?
Niacinamide
3
2012
103
0.120
Why?
Tankyrases
1
2016
13
0.120
Why?
Transcription Factor 7-Like 2 Protein
1
2016
26
0.120
Why?
Insulin-Like Growth Factor I
1
2018
320
0.120
Why?
Specimen Handling
1
2017
178
0.120
Why?
G2 Phase Cell Cycle Checkpoints
3
2022
43
0.120
Why?
Gonanes
2
2013
23
0.120
Why?
Biliary Tract Neoplasms
1
2015
30
0.110
Why?
Myenteric Plexus
1
1995
4
0.110
Why?
Serrate-Jagged Proteins
1
2015
27
0.110
Why?
Jagged-1 Protein
1
2015
22
0.110
Why?
Small Cell Lung Carcinoma
1
2017
125
0.110
Why?
Drug-Related Side Effects and Adverse Reactions
5
2017
266
0.110
Why?
Spectrometry, Mass, Electrospray Ionization
2
2006
175
0.110
Why?
RNA, Small Interfering
2
2015
633
0.110
Why?
Fluorocarbons
2
2014
122
0.110
Why?
Gastrointestinal Diseases
1
2017
220
0.110
Why?
Gene Duplication
1
2015
67
0.110
Why?
Device Approval
1
2015
19
0.110
Why?
Stomach Neoplasms
1
2017
128
0.110
Why?
Retinaldehyde
1
2015
4
0.110
Why?
Receptor, ErbB-3
1
2015
48
0.110
Why?
RNA Interference
3
2016
472
0.110
Why?
Prospective Studies
3
2025
8123
0.110
Why?
Cohort Studies
7
2024
6077
0.110
Why?
Acetaldehyde
1
2015
18
0.110
Why?
Young Adult
8
2024
14330
0.110
Why?
PTEN Phosphohydrolase
2
2015
166
0.110
Why?
Acridines
1
2014
10
0.110
Why?
Gene Expression Regulation
1
2024
2599
0.110
Why?
Nitric Oxide Synthase
1
1995
233
0.110
Why?
Protein Isoforms
1
2016
391
0.110
Why?
Drug Approval
1
2015
94
0.100
Why?
Muscle, Smooth
1
1995
152
0.100
Why?
Fatigue
4
2012
363
0.100
Why?
Immunoglobulin G
2
2017
901
0.100
Why?
Neuropilin-1
1
2014
8
0.100
Why?
Drug Screening Assays, Antitumor
3
2020
194
0.100
Why?
RNA, Messenger
4
2020
2791
0.100
Why?
Piperidines
1
2015
225
0.100
Why?
United States Food and Drug Administration
1
2015
208
0.100
Why?
Calcium-Binding Proteins
1
2015
221
0.100
Why?
Proto-Oncogene Proteins c-met
1
2014
76
0.100
Why?
Chromatography, Liquid
2
2006
453
0.100
Why?
Protein Binding
2
2018
2244
0.100
Why?
Cell Growth Processes
1
2013
47
0.100
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2013
54
0.100
Why?
Sensitivity and Specificity
5
2009
1998
0.100
Why?
Hedgehog Proteins
1
2014
194
0.100
Why?
Precision Medicine
1
2017
462
0.100
Why?
Protein Processing, Post-Translational
1
2016
487
0.100
Why?
T-Lymphocytes, Regulatory
3
2022
415
0.090
Why?
Tandem Mass Spectrometry
2
2006
576
0.090
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2012
8
0.090
Why?
Esophageal Neoplasms
1
2017
351
0.090
Why?
Random Allocation
1
2013
366
0.090
Why?
Patient Selection
3
2018
728
0.090
Why?
Uveal Neoplasms
1
2012
16
0.090
Why?
Demography
2
2010
274
0.090
Why?
Aldehyde Dehydrogenase, Mitochondrial
3
2017
23
0.090
Why?
Chemokine CXCL12
1
2012
85
0.090
Why?
Receptors, CXCR4
1
2012
91
0.090
Why?
Immunoprecipitation
1
2012
150
0.090
Why?
Cholangiocarcinoma
1
2013
110
0.090
Why?
Flow Cytometry
2
2019
1163
0.090
Why?
Transplantation, Heterologous
4
2016
165
0.080
Why?
Polyneuropathies
1
2011
57
0.080
Why?
Exanthema
2
2018
86
0.080
Why?
Blotting, Western
2
2013
1177
0.080
Why?
Magnetic Resonance Imaging
2
2018
3926
0.080
Why?
CA-19-9 Antigen
1
2010
36
0.080
Why?
Thiazoles
1
2011
139
0.080
Why?
Organoids
2
2024
143
0.080
Why?
Mitogen-Activated Protein Kinase Kinases
1
2010
126
0.080
Why?
Estrenes
1
2010
12
0.080
Why?
Receptors, Cell Surface
1
2012
371
0.080
Why?
Hepatectomy
2
2016
256
0.080
Why?
Reproducibility of Results
6
2010
3416
0.080
Why?
DNA Primers
2
2009
487
0.080
Why?
Nucleic Acid Denaturation
1
2009
32
0.080
Why?
Tissue Fixation
1
2009
35
0.080
Why?
Paraffin Embedding
1
2009
33
0.080
Why?
DNA Damage
2
2024
439
0.070
Why?
Homozygote
1
2010
197
0.070
Why?
Oncogene Protein pp60(v-src)
1
2009
4
0.070
Why?
Formaldehyde
1
2009
66
0.070
Why?
Proto-Oncogene Proteins pp60(c-src)
1
2009
14
0.070
Why?
Carcinoma, Renal Cell
1
2012
231
0.070
Why?
Caveolin 1
1
2009
20
0.070
Why?
Cell Separation
1
2010
300
0.070
Why?
Oximes
2
2022
26
0.070
Why?
Emergency Service, Hospital
1
2001
2363
0.070
Why?
Risk Assessment
3
2015
3712
0.070
Why?
Aminoquinolines
1
2008
18
0.070
Why?
Drug Monitoring
1
2012
399
0.070
Why?
Dioxoles
1
2008
9
0.070
Why?
Tetrahydroisoquinolines
1
2008
8
0.070
Why?
Watchful Waiting
2
2019
90
0.070
Why?
Dioxolanes
1
2008
6
0.070
Why?
Radiopharmaceuticals
1
2009
210
0.070
Why?
Fluorodeoxyglucose F18
1
2009
164
0.070
Why?
Lymphocytes, Tumor-Infiltrating
2
2020
156
0.070
Why?
Cytosine
1
2008
49
0.070
Why?
Hematologic Diseases
1
2008
66
0.070
Why?
Drug Delivery Systems
1
2011
377
0.070
Why?
Randomized Controlled Trials as Topic
3
2019
1763
0.070
Why?
Appointments and Schedules
1
2008
97
0.060
Why?
Kidney Neoplasms
1
2012
419
0.060
Why?
Colony-Stimulating Factors
1
2007
37
0.060
Why?
Protein Kinases
1
2009
311
0.060
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
974
0.060
Why?
Pharmacy Service, Hospital
1
2008
90
0.060
Why?
HT29 Cells
2
2018
37
0.060
Why?
Pharmacogenetics
1
2008
176
0.060
Why?
Cyclooxygenase Inhibitors
1
2006
82
0.060
Why?
Pyrroles
2
2022
222
0.060
Why?
Chemical and Drug Induced Liver Injury
1
2008
138
0.060
Why?
Antimitotic Agents
1
2006
8
0.060
Why?
Benzenesulfonates
1
2006
23
0.060
Why?
Blood Cells
1
2006
38
0.060
Why?
Midazolam
1
2006
69
0.060
Why?
Gene Expression
4
2019
1463
0.060
Why?
Cyclooxygenase 2
2
2006
166
0.060
Why?
Mice, Inbred C57BL
3
2023
6034
0.060
Why?
Estradiol
1
2010
517
0.060
Why?
Intention to Treat Analysis
1
2026
78
0.060
Why?
Bortezomib
1
2006
54
0.060
Why?
Proteasome Inhibitors
1
2006
42
0.060
Why?
Boronic Acids
1
2006
37
0.060
Why?
Evaluation Studies as Topic
1
2005
161
0.060
Why?
Incidence
2
2026
2936
0.060
Why?
Microsomes, Liver
1
2005
85
0.060
Why?
MicroRNAs
1
2012
699
0.060
Why?
Guideline Adherence
1
2010
594
0.060
Why?
Cost-Benefit Analysis
1
2008
640
0.060
Why?
Risk Factors
5
2026
10921
0.060
Why?
Phosphorylation
3
2018
1724
0.060
Why?
ATP-Binding Cassette Transporters
1
2005
117
0.050
Why?
Skin Neoplasms
1
2012
806
0.050
Why?
Spheroids, Cellular
2
2016
81
0.050
Why?
Proteasome Endopeptidase Complex
1
2006
155
0.050
Why?
Genotype
1
2010
1879
0.050
Why?
Tumor Necrosis Factor-alpha
1
2009
1224
0.050
Why?
Blood Proteins
1
2006
239
0.050
Why?
Anemia
1
2006
190
0.050
Why?
Rituximab
1
2025
208
0.050
Why?
Microsatellite Repeats
1
2024
159
0.050
Why?
Enzyme-Linked Immunosorbent Assay
1
2005
846
0.050
Why?
Transcription, Genetic
2
2020
1432
0.050
Why?
Prostaglandin-Endoperoxide Synthases
1
2003
76
0.050
Why?
Age Factors
2
2021
3347
0.050
Why?
Ataxia Telangiectasia Mutated Proteins
1
2022
69
0.050
Why?
Epidermal Growth Factor
1
2003
157
0.050
Why?
Dogs
3
2010
517
0.050
Why?
Age of Onset
1
2024
558
0.050
Why?
Acetonitriles
1
2022
12
0.040
Why?
Polymorphism, Single Nucleotide
1
2010
2240
0.040
Why?
Prostatic Neoplasms
1
2009
972
0.040
Why?
Isoenzymes
1
2003
294
0.040
Why?
Inflammasomes
1
2023
145
0.040
Why?
G2 Phase
2
2014
39
0.040
Why?
Academic Medical Centers
1
2025
561
0.040
Why?
Cisplatin
1
2024
347
0.040
Why?
Analysis of Variance
1
2004
1298
0.040
Why?
Cancer Vaccines
1
2003
161
0.040
Why?
Calibration
3
2006
154
0.040
Why?
Reference Standards
3
2006
176
0.040
Why?
Cell Division
2
2016
736
0.040
Why?
Oncogenes
1
2022
113
0.040
Why?
Medical Audit
1
2001
78
0.040
Why?
Hospitals, University
1
2001
178
0.040
Why?
Chimerism
1
2021
35
0.040
Why?
Pyrrolidines
1
2022
127
0.040
Why?
Immune Tolerance
1
2023
386
0.040
Why?
Extracellular Matrix
1
2025
565
0.040
Why?
Lymphocyte Subsets
1
2021
79
0.040
Why?
Medical Records
1
2001
193
0.040
Why?
Algorithms
2
2024
1849
0.040
Why?
Lymphoid Tissue
1
2021
82
0.040
Why?
Biomarkers
3
2019
4340
0.040
Why?
Biosimilar Pharmaceuticals
1
2021
28
0.040
Why?
Mice, SCID
1
2021
360
0.040
Why?
RNA, Neoplasm
1
2020
76
0.040
Why?
Carcinogenesis
1
2022
226
0.040
Why?
Mechanistic Target of Rapamycin Complex 2
1
2020
62
0.040
Why?
Poly-ADP-Ribose Binding Proteins
1
2019
35
0.040
Why?
Binding, Competitive
1
2019
185
0.040
Why?
In Vitro Techniques
2
2005
1041
0.040
Why?
Wnt Proteins
1
2020
131
0.040
Why?
Adenomatous Polyposis Coli Protein
1
2019
20
0.040
Why?
Smad4 Protein
1
2019
33
0.040
Why?
Mechanistic Target of Rapamycin Complex 1
1
2020
141
0.040
Why?
Mice, Inbred NOD
1
2021
598
0.040
Why?
Transcriptome
2
2016
1068
0.040
Why?
Small Molecule Libraries
1
2020
113
0.040
Why?
Survivorship
1
2019
62
0.040
Why?
M Phase Cell Cycle Checkpoints
1
2018
23
0.040
Why?
Drug Therapy, Combination
2
2016
1036
0.040
Why?
Research Personnel
1
2020
190
0.030
Why?
Colostomy
1
2018
28
0.030
Why?
Structure-Activity Relationship
1
2019
563
0.030
Why?
4-Aminobenzoic Acid
1
2018
8
0.030
Why?
High-Throughput Screening Assays
1
2020
179
0.030
Why?
Calcium
2
2013
1181
0.030
Why?
Predictive Value of Tests
3
2009
2113
0.030
Why?
Rats
3
2010
5586
0.030
Why?
Radiotherapy
1
2019
209
0.030
Why?
Induction Chemotherapy
1
2018
87
0.030
Why?
Adolescent
3
2024
22557
0.030
Why?
Anal Canal
1
2018
101
0.030
Why?
DNA Topoisomerases, Type I
1
2017
15
0.030
Why?
Adenine
1
2020
339
0.030
Why?
Glucuronosyltransferase
1
2017
18
0.030
Why?
Response Evaluation Criteria in Solid Tumors
1
2017
21
0.030
Why?
RNA
1
2024
926
0.030
Why?
Education
1
2017
103
0.030
Why?
Retreatment
1
2017
79
0.030
Why?
Adenosine Triphosphate
1
2019
494
0.030
Why?
fas Receptor
1
1997
91
0.030
Why?
Protein Transport
1
2018
443
0.030
Why?
Rectum
1
2018
180
0.030
Why?
Recombinant Proteins
1
2020
1361
0.030
Why?
Esophagogastric Junction
1
2017
54
0.030
Why?
Retinal Dehydrogenase
1
2016
27
0.030
Why?
Inhibitory Concentration 50
1
2016
90
0.030
Why?
Axin Protein
1
2016
18
0.030
Why?
Radiotherapy, Intensity-Modulated
1
2017
143
0.030
Why?
Cell Movement
1
2021
951
0.030
Why?
Hyaluronan Receptors
1
2016
105
0.030
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2016
104
0.030
Why?
Tissue Array Analysis
1
2016
49
0.030
Why?
Leadership
1
2020
414
0.030
Why?
Protein Interaction Maps
1
2016
54
0.030
Why?
Papillomaviridae
1
2016
113
0.030
Why?
Chromatin Immunoprecipitation
1
2016
139
0.030
Why?
Flavin Mononucleotide
1
1995
7
0.030
Why?
Gene Rearrangement, delta-Chain T-Cell Antigen Receptor
1
1995
4
0.030
Why?
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor
1
1995
8
0.030
Why?
Palliative Care
1
2024
1032
0.030
Why?
Polymyositis
1
1995
13
0.030
Why?
Flavin-Adenine Dinucleotide
1
1995
15
0.030
Why?
NADP
1
1995
52
0.030
Why?
Dermatomyositis
1
1995
24
0.030
Why?
Ligands
1
2017
678
0.030
Why?
Calmodulin
1
1995
70
0.030
Why?
History, Ancient
1
2015
54
0.030
Why?
Diagnosis, Differential
1
2019
1503
0.030
Why?
Diphenylamine
1
2014
7
0.030
Why?
Citrulline
1
1995
45
0.030
Why?
Receptors, Antigen, T-Cell, gamma-delta
1
1995
103
0.030
Why?
Zinc Finger Protein GLI1
1
2014
23
0.030
Why?
Cadherins
1
2016
202
0.030
Why?
Early Termination of Clinical Trials
1
2014
18
0.030
Why?
Acid Phosphatase
1
2014
15
0.030
Why?
Propensity Score
1
2017
376
0.030
Why?
Hematopoietic Stem Cell Transplantation
1
2021
704
0.030
Why?
Myositis
1
1995
57
0.030
Why?
Gene Expression Regulation, Enzymologic
1
2016
266
0.030
Why?
Rhodamines
1
2014
20
0.030
Why?
Oxaloacetates
1
2014
2
0.030
Why?
Ileum
1
1995
112
0.030
Why?
Oncogene Proteins
1
2014
61
0.030
Why?
Rats, Wistar
1
1995
451
0.030
Why?
Sequence Analysis, RNA
1
2016
441
0.030
Why?
Tretinoin
1
2015
115
0.030
Why?
GTP Phosphohydrolases
1
2014
95
0.030
Why?
Histones
2
2010
670
0.030
Why?
Arginine
1
1995
264
0.020
Why?
Proportional Hazards Models
1
2017
1331
0.020
Why?
Mice, Knockout
1
2021
3125
0.020
Why?
Genomics
1
2019
853
0.020
Why?
Multivariate Analysis
1
2017
1543
0.020
Why?
Transfection
1
2016
916
0.020
Why?
Severity of Illness Index
1
2001
2921
0.020
Why?
Receptor, Notch2
1
2013
15
0.020
Why?
Antigens, CD
1
2016
560
0.020
Why?
Neutrophils
1
2019
1133
0.020
Why?
Alphapapillomavirus
1
2013
35
0.020
Why?
Bile Ducts, Intrahepatic
1
2013
62
0.020
Why?
Autoimmune Diseases
1
1997
467
0.020
Why?
Up-Regulation
1
2016
841
0.020
Why?
Receptors, CXCR
1
2012
5
0.020
Why?
CD8-Positive T-Lymphocytes
1
2019
931
0.020
Why?
Phenotype
1
2021
3206
0.020
Why?
Surveys and Questionnaires
1
2025
6073
0.020
Why?
Cyclin D1
1
2012
64
0.020
Why?
Trans-Activators
1
2014
372
0.020
Why?
Patient Care Team
1
2018
701
0.020
Why?
Chi-Square Distribution
1
2013
517
0.020
Why?
Logistic Models
1
2017
2126
0.020
Why?
Intracellular Signaling Peptides and Proteins
1
2015
457
0.020
Why?
Multiple Sclerosis
1
1997
435
0.020
Why?
Lymphopenia
1
2012
62
0.020
Why?
Nausea
1
2012
111
0.020
Why?
Hospital Mortality
1
2016
1051
0.020
Why?
Hydroxamic Acids
1
2012
96
0.020
Why?
Antioxidants
1
1995
544
0.020
Why?
Bile Duct Neoplasms
1
2013
132
0.020
Why?
Vomiting
1
2012
131
0.020
Why?
Databases, Factual
1
2017
1493
0.020
Why?
Calcium Signaling
1
2013
246
0.020
Why?
Models, Biological
1
2018
1761
0.020
Why?
Aurora Kinases
1
2010
25
0.020
Why?
Proto-Oncogene Proteins c-myc
1
2012
157
0.020
Why?
Thalidomide
1
2010
43
0.020
Why?
DNA Methylation
1
2016
725
0.020
Why?
Thrombocytopenia
1
2012
206
0.020
Why?
Lung
1
2023
4122
0.020
Why?
Keratinocytes
1
2010
190
0.020
Why?
Paxillin
1
2009
11
0.020
Why?
Models, Molecular
1
2014
1574
0.020
Why?
Focal Adhesion Kinase 1
1
2009
32
0.020
Why?
Infliximab
1
2009
107
0.020
Why?
Glucose Transporter Type 1
1
2009
49
0.020
Why?
Pilot Projects
1
2014
1888
0.020
Why?
Species Specificity
1
2010
543
0.020
Why?
T-Lymphocytes
1
1997
2012
0.020
Why?
Xenopus laevis
1
2008
101
0.020
Why?
Computational Biology
1
2013
678
0.020
Why?
Indoles
1
2012
511
0.020
Why?
Genetic Markers
1
2009
340
0.020
Why?
Staurosporine
1
2007
22
0.020
Why?
Acetylation
1
2008
262
0.020
Why?
Probability
1
2008
309
0.020
Why?
Membrane Transport Proteins
1
2008
154
0.020
Why?
Cyclooxygenase 1
1
2006
27
0.020
Why?
Gene Frequency
1
2008
496
0.020
Why?
Celecoxib
1
2006
41
0.020
Why?
Infusions, Intra-Arterial
1
2006
61
0.020
Why?
Clinical Chemistry Tests
1
2006
6
0.020
Why?
Hepatic Artery
1
2006
53
0.020
Why?
Injections, Intraperitoneal
1
2006
115
0.010
Why?
Leukocytes
1
2008
301
0.010
Why?
Dinoprostone
1
2006
179
0.010
Why?
Injections, Subcutaneous
1
2006
170
0.010
Why?
Gadolinium DTPA
1
2006
70
0.010
Why?
Leukocytes, Mononuclear
1
2008
585
0.010
Why?
HIV Protease Inhibitors
1
2005
69
0.010
Why?
Proto-Oncogene Proteins c-bcl-2
1
2006
237
0.010
Why?
Interleukin-6
1
2009
784
0.010
Why?
Ritonavir
1
2005
76
0.010
Why?
Molecular Structure
1
2006
484
0.010
Why?
Substrate Specificity
1
2005
389
0.010
Why?
Tubulin
1
2005
124
0.010
Why?
Chromatography, High Pressure Liquid
1
2005
588
0.010
Why?
Longitudinal Studies
1
2011
3017
0.010
Why?
Feasibility Studies
1
2008
1135
0.010
Why?
Kinetics
1
2006
1553
0.010
Why?
Genetic Variation
1
2008
996
0.010
Why?
Contrast Media
1
2006
493
0.010
Why?
Cell Line
1
2008
2814
0.010
Why?
Mass Spectrometry
1
2005
729
0.010
Why?
Hypertension
1
2010
1272
0.010
Why?
Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor
1
1997
21
0.010
Why?
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor
1
1997
27
0.010
Why?
Myelin Basic Protein
1
1997
44
0.010
Why?
Clone Cells
1
1997
259
0.010
Why?
Cell Death
1
1997
379
0.010
Why?
Receptors, Antigen, T-Cell, alpha-beta
1
1997
330
0.010
Why?
Multigene Family
1
1995
210
0.010
Why?
Sequence Alignment
1
1995
360
0.010
Why?
Autoantigens
1
1997
426
0.010
Why?
Base Sequence
1
1995
2123
0.010
Why?
Amino Acid Sequence
1
1995
2092
0.010
Why?
Molecular Sequence Data
1
1995
2838
0.010
Why?
Messersmith's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)